Healthcare Cost and Utilization Project

Healthcare Cost and Utilization Project
Name	Healthcare Cost and Utilization Project
Formed	1988
Jurisdiction	United States
Headquarters	Rockville, Maryland
Parent agency	Agency for Healthcare Research and Quality

Healthcare Cost and Utilization Project

The Healthcare Cost and Utilization Project is a family of databases and research resources supporting health services research, policy analysis, and administrative data studies in the United States. Managed by the Agency for Healthcare Research and Quality and produced in collaboration with state partners and vendors, the project supplies inpatient, outpatient, and emergency care data used by analysts at institutions such as Harvard University, Johns Hopkins University, Columbia University, University of California, San Francisco, and University of Michigan. Its outputs inform stakeholders including the Centers for Medicare & Medicaid Services, Kaiser Family Foundation, and private sector entities like IBM and UnitedHealth Group.

Overview

The project aggregates standardized hospital discharge and facility-level administrative records drawn from state Data Use Agreements and national sources, enabling comparisons across populations, time, and geography. Researchers from Yale University, Stanford University, Massachusetts General Hospital, Mayo Clinic, and Cleveland Clinic use the resources for analyses of utilization patterns, cost drivers, and quality measures. Public policy organizations such as the Brookings Institution, RAND Corporation, and Pew Charitable Trusts have employed the datasets for evaluations tied to programs like Medicaid expansion, Affordable Care Act, and Medicare payment reforms.

History and Development

Initiated in the late 1980s under the auspices of the Agency for Healthcare Research and Quality and predecessors linked to the Department of Health and Human Services, the project expanded through partnerships with state health agencies, academic centers, and commercial vendors. Early adopters included analysts at University of Pennsylvania, University of Washington, and Duke University, while influential policy uses were produced by Congressional Budget Office staff and analysts at Office of Management and Budget. Over successive decades the initiative incorporated coding transitions such as ICD-9 and ICD-10, and adapted to changes in billing driven by entities like Blue Cross Blue Shield and American Medical Association.

Data Sources and Methodology

Primary sources include state-wide inpatient discharge abstracts, emergency department records, and ambulatory surgery files submitted by hospitals and licensed facilities. Data contributors range from state agencies such as the California Health and Human Services Agency, New York State Department of Health, and Florida Agency for Health Care Administration to proprietary data assemblers and health information exchanges. Methodological components involve standardized elements like diagnosis and procedure codes from ICD-9, ICD-10, and Current Procedural Terminology, as well as cost estimation techniques informed by Medicare cost reports, hospital charge-to-cost ratios, and payer mix adjustments used by analysts at Harvard Pilgrim Health Care and Blue Cross Blue Shield Association.

Data Products and Filesets

Available products include national and state-level inpatient databases, emergency department datasets, and trend files used by organizations such as SAS Institute and RStudio-based research groups. Notable filesets mirror outputs used in publications from New England Journal of Medicine, JAMA, Health Affairs, and Annals of Internal Medicine, and facilitate construction of measures like length of stay, readmission rates, and procedural volumes. Commercial and academic users often integrate these files with external sources like the American Hospital Association Annual Survey, Census Bureau population estimates, and the National Center for Health Statistics to produce enriched analytic datasets.

Research Uses and Policy Impact

Analyses leveraging the project have shaped evidence cited by Congress, the Centers for Medicare & Medicaid Services, and advocacy organizations such as Families USA and Commonwealth Fund. Research topics include trends in surgical utilization studied at Brigham and Women's Hospital, opioid-related hospitalization patterns examined by investigators at Yale School of Medicine, and cost variation analyses referenced in work by Brookings Institution scholars. The data underpin quality measurement efforts used by The Joint Commission and inform payment reform pilots connected to Accountable Care Organizations and demonstrations run by the Center for Medicare and Medicaid Innovation.

Access, Licensing, and Privacy

Access mechanisms range from public use files with de-identified records to restricted datasets subject to Data Use Agreements and institutional review by bodies like Institutional Review Board offices at universities including Columbia University and University of California, Los Angeles. Licensing and purchase channels involve the project office, state data stewards, and licensed vendors; purchasers must often comply with privacy standards influenced by HIPAA and guidance from the Office for Civil Rights (United States Department of Health and Human Services). Data security practices align with standards used by National Institutes of Health repositories and major academic data cores.

Limitations and Criticisms

Limitations cited by scholars at George Washington University, Princeton University, and University of Pennsylvania include variable state reporting, lack of clinical detail compared with electronic health record systems like those at Geisinger Health System and potential misclassification stemming from coding transitions such as from ICD-9 to ICD-10. Critics from think tanks including Manhattan Institute and advocates from Patients for Affordable Drugs note concerns about timeliness, representativeness, and accessibility for under-resourced investigators, while legal scholars from Harvard Law School have highlighted regulatory constraints affecting secondary use.